Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

NCT01904604 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

NIH

Sponsor class

Conditions

Peanut Hypersensitivity
Food Hypersensitivity
Hypersensitivity
Hypersensitivity, Immediate

Interventions

BIOLOGICAL: Placebo Viaskin® Patch
BIOLOGICAL: Low-dose DBV712 Viaskin® Patch
BIOLOGICAL: High-dose DBV712 Viaskin® Patch

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]